MANAGING POST-PDT STRICTURE
AFTER OESOPHAGEAL TREATMENT
Oesophageal stricture is a known and manageable complication of PDT โ not a treatment failure. Understanding when it occurs, what causes it, and how it is managed helps patients prepare for one of the most common post-PDT challenges.
analyticsAt a Glance
- check_circleStricture in 5โ20% overall; up to 30% after circumferential PDT
- check_circleDevelops 4โ12 weeks after PDT as healed tissue contracts and scars
- check_circlePresents as new or returning difficulty swallowing after initial PDT improvement
- check_circleMost strictures resolve with 1โ3 endoscopic balloon dilation sessions
Why Oesophageal Stricture Forms After PDT
Stricture formation after oesophageal PDT is not a random complication โ it is a predictable consequence of the healing process in the oesophageal wall. Understanding why it occurs helps patients recognise it early and present for timely management.
โPost-PDT stricture is scar tissue, not tumour recurrence. The two can feel identical โ both cause dysphagia returning weeks after treatment. The distinction is critical: stricture is treated with dilation; recurrence needs different management.โ
The Scar Formation Mechanism
PDT destroys the tumour and a margin of oesophageal wall. As this tissue undergoes necrosis and is cleared, the healing process โ granulation tissue formation, fibroblast infiltration, and collagen deposition โ produces scar tissue. If this scar formation is circumferential (all the way around the oesophageal lumen), the resulting scar contraction narrows the lumen, producing stricture.
The Distinction from Tumour Recurrence
The clinical presentation of post-PDT stricture is identical to tumour recurrence โ progressive dysphagia beginning weeks to months after treatment. The distinction must be made by endoscopy with biopsy: stricture shows smooth fibrotic narrowing with no tumour on biopsy; recurrence shows irregular mucosal lesion with tumour on biopsy. This distinction drives completely different management.
Risk Factors for Post-PDT Stricture
Stricture risk varies substantially based on the type and extent of PDT treatment. Higher-risk cases can be identified in advance.
| Risk Factor | Stricture Risk | Clinical Note |
|---|---|---|
| Circumferential PDT (full circumference of oesophagus treated) | High โ 20โ30% | Cannot be avoided for some tumour locations; patients must be counselled prospectively |
| Barrett's HGD ablation (long segment, circumferential) | High โ 20โ30% | Long-segment Barrett's ablation is inherently higher risk |
| Partial circumferential PDT | Moderate โ 5โ10% | Non-circumferential treatment substantially lower risk |
| Short segment PDT (<5 cm length) | Lower โ 5โ10% | Shorter length = less scar surface = lower stricture risk |
| Long segment PDT (>8 cm) | Higher โ 15โ25% | More extensive treatment = more healing and potential scarring |
| Multiple PDT sessions | Increased with each additional session | Cumulative scar formation from repeated treatments |
| Prior radiation to oesophagus | Increased โ radiation fibrosis + PDT scar | Combined injury produces higher stricture risk |
| Underlying eosinophilic oesophagitis | Increased | Pre-existing oesophageal scarring tendency |
Detecting and Managing Post-PDT Stricture
The management pathway from initial suspicion through definitive treatment.
- 1
Step 1: Recognising the Symptom โ Recurrent Dysphagia
Post-PDT stricture typically develops 4โ12 weeks after treatment. The warning sign is dysphagia (difficulty swallowing) that initially improves after PDT but then progressively returns. Patients should be counselled before PDT to report any return of swallowing difficulty promptly โ early strictures are easier to dilate than established ones.
- 2
Step 2: Endoscopy and Biopsy to Confirm Stricture vs Recurrence
Urgent endoscopy is the essential first step. The endoscopist assesses the nature of the narrowing: smooth fibrotic stricture vs irregular mucosal lesion. Biopsies are taken from the stricture to exclude tumour recurrence. CT chest may be performed if extraluminal recurrence is suspected. The management pathway depends entirely on this distinction.
- 3
Step 3: Endoscopic Balloon Dilation (First-Line Treatment)
For confirmed fibrotic stricture without tumour, endoscopic balloon dilation is the standard treatment. A through-the-scope (TTS) balloon or Savary-Gilliard dilator is used to gently expand the narrowed segment. Graduated dilation from a smaller to a larger diameter over 1โ3 sessions achieves the target lumen diameter (typically 14โ16 mm for comfortable swallowing).
- 4
Step 4: Intralesional Steroid Injection (For Recurrent Strictures)
For strictures that recur rapidly after dilation (refractory strictures), intralesional injection of triamcinolone acetonide (typically 40โ80 mg in 4 quadrants around the stricture) reduces fibroblast activity and collagen formation, reducing the rate of re-stricture. Combined with dilation at the same session.
- 5
Step 5: Stenting (For Severe or Refractory Strictures)
For strictures that do not respond to repeated dilation + steroid injection, temporary placement of a fully covered self-expanding metal or plastic stent provides sustained luminal patency. Stents are typically removed after 4โ8 weeks. The aim is to provide a scaffold for healing in a dilated configuration.
- 6
Step 6: Ongoing Surveillance
After successful stricture management, surveillance endoscopy at 3-monthly intervals monitors for re-stricture and tumour recurrence. Most patients do not require further dilation after 1โ3 successful sessions; a minority develop progressive or recurrent strictures requiring ongoing management.
Prevention Strategies: Reducing Stricture Risk
While stricture after circumferential PDT cannot always be prevented, several strategies reduce risk and severity.
Minimise Circumferential Treatment When Possible
When the PDT indication allows, treating less than the full oesophageal circumference substantially reduces stricture risk. For eccentric tumours or focal HGD patches, partial circumferential light delivery is achievable. For circumferential disease, full circumferential treatment is unavoidable but patients should be counselled prospectively.
Prophylactic Oral Steroids After Circumferential PDT
Some centres prescribe a 4โ6 week course of oral prednisone (starting 1โ3 days after PDT) for high-risk circumferential treatments. Evidence is modest but supports some reduction in stricture rate and severity. The decision to use prophylactic steroids should be made by the treating team based on individual risk assessment.
Early Dilation at First Surveillance Endoscopy
Rather than waiting for symptomatic stricture to develop, some protocols include prophylactic dilation at the 4โ6 week surveillance endoscopy if incipient narrowing is visible โ before the stricture becomes symptomatic. Early intervention when the stricture is forming is more easily managed than established tight stricture.
Staged PDT for Long Segment Disease
For very long segment treatment areas (>10 cm), staged PDT โ treating proximal and distal sections in separate sessions weeks apart โ may reduce the total circumferential scar area healed simultaneously, potentially reducing stricture severity. This approach is used at some specialist centres for high-risk situations.
Explore the PDT Knowledge Base
Related PDT topics and resources.
Frequently Asked Questions
Common questions about post-PDT oesophageal stricture.
About Stricture
How will I know if I have a stricture rather than tumour coming back?
Symptomatically, you cannot tell the difference โ both cause progressive dysphagia returning after initial improvement. The distinction requires an endoscopy with biopsy. Report any return of swallowing difficulty to your treating team promptly โ do not wait for scheduled surveillance if symptoms develop earlier. At endoscopy, stricture looks like smooth narrowing; recurrence looks like irregular mucosal lesion. Biopsies confirm.
Is stricture dilation painful?
Endoscopic dilation is performed under conscious sedation โ patients feel little during the procedure. There is typically mild soreness or discomfort in the chest for 24โ48 hours after dilation. Severe pain, fever, or difficulty breathing after dilation warrants urgent assessment as it may indicate perforation (rare, <1%). Most patients find dilation much more comfortable than their dysphagia and are relieved by the immediate improvement in swallowing.
Will I need stricture dilation repeatedly for the rest of my life?
Most post-PDT strictures resolve with 1โ3 dilation sessions and do not recur or require ongoing treatment. A minority of patients โ particularly after high-risk circumferential PDT of long Barrett's segments โ develop progressive or recurrent strictures requiring regular maintenance dilation (every 3โ6 months indefinitely). Your treating team can usually predict after 2โ3 dilation sessions whether you are likely to be a "dilate and done" or a "dilate and maintain" patient.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Developing Difficulty Swallowing After Oesophageal PDT?
Contact your treating centre promptly โ return of dysphagia after PDT needs endoscopic assessment to distinguish stricture from recurrence. Our team can also advise on centre referral if stricture management expertise is needed.
For informational purposes only. New or worsening dysphagia after PDT requires prompt medical assessment. Do not self-manage swallowing symptoms without endoscopic evaluation.